Dr. Gregory William Basil, MD

Dr. Basil practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Basil's NPI, 1245624386, was assigned on March 26, 2015. Dr. Basil graduated from Tufts University School Of Medicine in 2015. Dr. Basil holds Florida license ME154718.

Dr. Basil's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Dr. Basil's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Basil is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Basil to 1 more hospital and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basil practices, 3 sites in all. Vendor and product names are available with a free account.

Neurological surgery is Dr. Basil's primary specialty in the NPI Registry, under taxonomy code 207T00000X. Dr. Basil is board certified in neurological surgery by the American Board of Neurological Surgery. Dr. Basil is licensed in Florida.

Dmand AI lists back and neck pain treatment without fusion, lower back pain, muscle pain, fibromyalgia, and limb pain, neck pain and spine problems, spinal fusion and thoracic spine disorders among the conditions Dr. Basil treats.

CMS data shows 239 Medicare services from Dr. Basil across 5 procedure codes in 2024, all of them office visits, for 168 Medicare patients. Medicare paid $17,275 for them.

CMS counts 168 Medicare patients who saw Dr. Basil in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have arthritis, and 75% have high blood pressure. 15% are also on Medicaid. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Basil's median patient age at 67, with 50% women.

In 2024, Dr. Basil wrote 373 Medicare Part D claims for 119 patients. 100% of them were for generic drugs. CMS names the drug for 329 of them, across 6 drugs with 11 or more claims each, at $4,480 in total drug cost. In 2023, CMS named 228 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Basil for performance year 2024, reported as part of a group. Dr. Basil accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Basil as offering telehealth. CMS counts 40 procedures of laminectomy or laminotomy (partial removal of spine bones) by Dr. Basil, more than 70% of the clinicians it reports for that procedure.

Dmand AI links 53 papers to Dr. Basil, published from 2016 to 2025. 2020 was the busiest year, with 9. The most frequent topics are Spinal Fusion, Lumbar Vertebrae and Cervical Vertebrae. Dr. Basil has published most often in Cureus. Dr. Basil's most frequent co-authors are Michael Yung-Shun Wang, MD, Michael Y. Wang, MD and Allan D. Levi, MD, PhD.

CMS Open Payments shows 262 general payments to Dr. Basil from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Globus Medical, Inc. paid the most, $41,456.

Dmand AI lists 1 award for Dr. Basil.

Dr. Basil graduated from Tufts University School Of Medicine in 2015.

Dr. Basil is in network with 9 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.